Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens

Saved in:
Bibliographic Details
Published in:JAC-Antimicrobial Resistance
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553802900045825
collection WordPress RSS
FRELIP Feed Integration
container_title JAC-Antimicrobial Resistance
description
discipline_display Internal Medicine
discipline_facet Internal Medicine
format Online Article
RSS Article
genre Journal Article
id rss_article:88944
institution FRELIP
journal_source_facet JAC-Antimicrobial Resistance
last_indexed 2026-06-20T21:42:46.854Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
Internal Medicine
General
Internal Medicine
sub_discipline_display General
sub_discipline_facet General
subject_display Internal Medicine
General
Internal Medicine
subject_facet Internal Medicine
General
Internal Medicine
title Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
title_alt Actualización sobre la actividad comparativa in vitro de cefiderocol y cuatro combinaciones de β-lactámico–β-lactamasa-inhibidor contra patógenos Gram-negativos clínicamente importantes
Mise à jour sur l'activité comparative in vitro du céfidérocol et de quatre combinaisons β-lactamine–inhibiteur de β-lactamase contre des pathogènes Gram-négatifs cliniquement importants
Atualização sobre a atividade comparativa in vitro de cefiderocol e quatro combinações de β-lactâmico–β-lactamase-inibidor contra patógenos Gram-negativos clinicamente importantes
title_auth Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
title_es_txt Actualización sobre la actividad comparativa in vitro de cefiderocol y cuatro combinaciones de β-lactámico–β-lactamasa-inhibidor contra patógenos Gram-negativos clínicamente importantes
title_fr_txt Mise à jour sur l'activité comparative in vitro du céfidérocol et de quatre combinaisons β-lactamine–inhibiteur de β-lactamase contre des pathogènes Gram-négatifs cliniquement importants
title_full Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
title_fullStr Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
title_full_unstemmed Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
title_pt_txt Atualização sobre a atividade comparativa in vitro de cefiderocol e quatro combinações de β-lactâmico–β-lactamase-inibidor contra patógenos Gram-negativos clinicamente importantes
title_short Update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens
title_sort update on the comparative in vitro activity of cefiderocol and four β-lactam–β-lactamase-inhibitor combinations against clinically important gram-negative pathogens
topic Internal Medicine
General
Internal Medicine
url https://academic.oup.com/jacamr/article/doi/10.1093/jacamr/dlag103/8703636?rss=1